Lexicon Pharmaceuticals announced that its management will participate in a fireside chat at the 2026 Jefferies Global Healthcare Conference in London on November 18, 2026. The event will be accessible live and via replay on the company's website. Lexicon focuses on developing novel treatments for serious cardiometabolic diseases, including hypertrophic cardiomyopathy, type 1 diabetes, and obesity. This presentation provides an opportunity to highlight their clinical pipeline and ongoing research efforts.
Lexicon Pharmaceuticals' upcoming presentation at the Jefferies Global Healthcare Conference in London offers timely context for healthcare sector watchers. For readers following healthcare stocks, here is Pluang's market snapshot as of Nov 11, 2026 20:11 WIB: out of 150 priced US health-sector stocks, 69 rose and 74 fell today. Notable movers include Inovio Pharmaceuticals Inc (INO) down 10.54% at USD 1.31 with a typical hold time of 41 days and a Pluang order activity split of 28% Sell / 72% Buy, Twist Bioscience Corp (TWST) up 5.62% at USD 139.55 with a 27-day hold time, and InMode Ltd (INMD) up 4.60% at USD 13.88 with a 34-day hold time.
RUM Group Inc. reported a record quarterly revenue of $96.6 million for Q3 2026, a 290% increase year-over-year, surpassing expectations. Despite this, earnings per share were -$0.19, missing the estimate of -$0.11. The company achieved its first pro...
The 2026 Vertex CompOps™ Index reveals that just 16% of enterprises regularly discuss indirect tax at the board level, while 43% only address it when issues arise. Companies with board-level focus on indirect tax are four times less likely to have er...
Richtech Robotics announced its Intelligent Cleaning System at ISSA Show North America 2026, which integrates autonomous cleaning robots with CCTV cameras to enable proactive, targeted cleaning. This system uses real-time data to optimize cleaning ta...
Blue Gold Limited is reducing operating costs and restructuring its balance sheet to address financial obligations and comply with Nasdaq listing requirements. The company is cutting headcount, streamlining operations, and exploring creditor arrangem...
Longevity Health Holdings announced its Board is exploring strategic alternatives for its bio-aesthetic and therapeutic businesses to maximize stakeholder value. Options under consideration include mergers, sales, licensing, or partnerships. This mov...
